{'fraction_non_alphanumeric': 0.01905972045743329, 'fraction_numerical': 0.0019059720457433292, 'mean_word_length': 5.702127659574468, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Metabolism of orotic acid: lack of orotate phosphoribosyltransferase in rat intestinal mucosa.

The main enzymes involved in orotic acid metabolism, orotate phosphoribosyltransferase and orotidine 5'-phosphate decarboxylase, are associated as a multienzyme complex (complex U) which is present in the liver of most vertebrate species. Orotic-acid-enriched diets produce increased pyrimidine synthesis which competes with purine synthesis for 5-phosphoribosyl diphosphate, resulting in decreased adenylate levels in liver cells. Inhibition of secretion of very low density lipoproteins and hepatic steatosis is then observed. In contrast, lipoproteins secretion by the intestine is not impaired and fat does not accumulate in enterocytes. The aim of this work was to investigate whether orotate is differently metabolized in gut and in liver thus explaining the lack of effect on the intestinal lipoproteins secretion. Complex U was found in appreciable amounts in rat, mouse and rabbit livers; the intestinal mucosa of the two last species contains a much lower level of multienzyme complex whereas in rat intestine its activity cannot be detected. Indeed, radioactive aspartate and orotate were not incorporated into intestinal cells RNA. The absence of orotate metabolisation by lack of orotate phosphoribosyltransferase and orotidine 5'-phosphate decarboxylase activity in rat intestine would explain why this organ, in contrast to the liver, is protected against disturbances of nucleotide metabolism and lipoproteins secretion induced by orotic-acid-supplemented diets.